Aslan Turer, M.D., M.H.S., M.B.A., is an Associate Professor in the Department of Internal Medicine’s Division of Cardiology at UT Southwestern Medical Center. Dr. Turer is an interventional and general cardiologist with special expertise in evaluating and treating patients with inherited forms of cardiovascular disease – particularly hypertrophic cardiomyopathy (HCM). He is the Medical Director of the UT Southwestern Clinical Heart and Vascular Center and the co-director of the Hypertrophic Cardiomyopathy Center of Excellence.

Dr. Turer earned his medical degree at the University of California, San Francisco, School of Medicine. He completed an internal medicine residency, a cardiology fellowship, and a coronary and structural interventional cardiology fellowship at Duke University Medical Center, where he also conducted postdoctoral research.

He also holds a Master of Health Sciences degree from Duke University, a Master of Business Administration from Southern Methodist University, and a bachelor’s degree in biology from the University of California, Los Angeles.

Dr. Turer is board certified in internal medicine, interventional cardiology, and cardiovascular disease.

Dr. Turer’s previous research work included risk factors for coronary atherosclerosis, novel biomarkers in cardiac ischemia, and physiological factors in heart failure. He currently is involved in several studies of therapeutic and lifestyle interventions among symptomatic patients with hypertrophic cardiomyopathy.

He has published more than 40 journal articles and contributed to the books Post-operative Care of the Valvular Heart Disease Patient and Hypertrophic Cardiomyopathy.

Personal Note

He and his wife, Christy Boling Turer, M.D., M.H.S., have five children and innumerable pets.


Medical School
University of California, San Francisco (2001)
Duke University Medical Center (2004), Internal Medicine
Duke University Medical Center (2008), Cardiology
Duke University Medical Center (2009), Interventional Cardiology
Other Post Graduate Training
Duke University Medical Center (2009)


Featured Publications LegendFeatured Publications

Adiponectin: mechanistic insights and clinical implications.
Turer AT, Scherer PE Diabetologia 2012 Jun
Adiponectin as an independent predictor of the presence and degree of hepatic steatosis in the dallas heart study.
Turer AT, Browning JD, Ayers CR, Das SR, Khera A, Vega GL, Grundy SM, Scherer PE J. Clin. Endocrinol. Metab. 2012 Jun 97 6 E982-6
Correlations between physician-perceived functional status, patient-perceived health status, and cardiopulmonary exercise results in hypertrophic cardiomyopathy.
Huff CM, Turer AT, Wang A Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2012 Apr
Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.
Turer AT, Hill JA Am. J. Cardiol. 2010 Aug 106 3 360-8
Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure.
Allen LA, Turer AT, Dewald T, Stough WG, Cotter G, O'Connor CM Am. J. Cardiol. 2010 Jun 105 12 1794-7
Influence of body mass index on the efficacy of revascularization in patients with coronary artery disease.
Turer AT, Mahaffey KW, Honeycutt E, Tuttle RH, Shaw LK, Sketch MH Jr, Smith PK, Califf RM, Alexander JH. J Thorac Cardiovasc Surg June 2009 137(6) 1468-74

Honors & Awards

  • L. David Hillis Teaching Award
  • American College of Cardiology Young Investigator Award- 2nd Place
  • Society of Cardiovascular Angiography and Intervention/Cordis Fellowship Program Grant
  • AHA Laennec Young Clinician Award Finalist

Professional Associations/Affiliations

  • American Heart Association- Council of Functional Genomics and Translational Biology (2012)
  • American Heart Association- Council of Clinical Cardiology (2005)
  • American College of Cardiology (2004)